Prognostic Value of Elevated White Blood Cell Count in Hypertension

American Journal of Hypertension

Volumn 20, Issue 4, 2007, Pages 364-369

  Schillaci, Giuseppe ^a   Pirro, Matteo ^a   Pucci, Giacomo ^a   Ronti, Tiziana ^a   Vaudo, Gaetano ^a   Mannarino, Massimo R ^a   Porcellati, Carlo ^b   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Perugia General Hospital   (Italy)

Author keywords

hypertension; inflammation; morbidity; prognosis; White blood cell count

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLECYSTOKININ BLOOD LEVEL; CLINICAL EXAMINATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; COURSE EVALUATION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; ITALY; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MORBIDITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33947310264     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.10.007     Document Type: Article

References (34)

1. Rader D.J. Inflammatory markers of coronary risk. N Engl J Med 343 (2000) 1179-1182
2. Margolis K.L., Manson J.E., Greenland P., Rodabough R.J., Bray P.F., Safford M., Grimm Jr. R.H., Howard B.V., Assaf A.R., Prentice R., and Women's Health Iniative Research Group. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 165 (2005) 500-508
3. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., and Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96 (1997) 1102-1108
4. Grimm Jr. R.H., Neaton J.D., and Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 254 (1985) 1932-1937
5. Lee C.D., Folsom A.R., Nieto F.J., Chambless L.E., Shahar E., and Wolfe D.A. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: Atherosclerosis Risk In Communities study. Am J Epidemiol 154 (2001) 758-764
6. Sweetnam P.M., Thomas H.F., Yarnell J.W., Baker I.A., and Elwood P.C. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 145 (1997) 416-421
7. Brown D.W., Giles W.H., and Croft J.B. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 54 (2001) 316-322
8. Prentice R.L., Szatrowski T.P., Fujikura T., Kato H., Mason M.W., and Hamilton H.H. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol 116 (1982) 496-509
9. Manttari M., Manninen V., Koskinen P., Huttunen J.K., Oksanen E., Tenkanen L., Heinonen O.P., and Frick M.H. Leukocytes as a coronary risk factor in a dyslipidemic male population. Am Heart J 123 (1992) 873-877
10. Hajj-Ali R., Zareba W., Ezzeddine R., and Moss A.J. Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. Am J Cardiol 88 (2001) 1221-1224
11. Haim M., Boyko V., Goldbourt U., Battler A., and Behar S. Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease: the Bezafibrate Infarction Prevention Study. Arch Intern Med 164 (2004) 433-439
12. Barron H.V., Harr S.D., Radford M.J., Wang Y., and Krumholz H.M. The association between white blood cell count and acute myocardial infarction mortality in patients > or = 65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol 38 (2001) 1654-1661
13. Bovill E.G., Bild D.E., Heiss G., Kuller L.H., Lee M.H., Rock R., and Wahl P.W. White blood cell counts in persons aged 65 years or more from the Cardiovascular Health Study: correlations with baseline clinical and demographic characteristics. Am J Epidemiol 143 (1996) 1107-1115
14. Facchini F., Hollenbeck C.B., Chen Y.N., Chen Y.D., and Reaven G.M.L. Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med 232 (1992) 267-272
15. Freedman D.S., Joesoef M.R., Barboriak J.J., Stallone D.D., and Byers T.L. Correlates of leukocyte counts in men. Ann Epidemiol 6 (1996) 74-82
16. Friedman G.D., Tekawa I., Grimm R.H., Manolio T., Shannon S.G., and Sidney S.L. The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA Study. Int J Epidemiol 19 (1990) 889-893
17. Rader D.J., Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., Gallimore J.R., and Pepys M.B. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
18. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., and Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96 (1997) 1102-1108
19. Nakanishi N., Sato M., Shirai K., Suzuki K., and Tatara K. White blood cell count as a risk factor for hypertension; a study of Japanese male office workers. J Hypertens 20 (2002) 851-857
20. Schillaci G., Pirro M., Gemelli F., Pasqualini L., Vaudo G., Marchesi S., Siepi D., Bagaglia F., and Mannarino E. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens 21 (2003) 1841-1846
21. Schillaci G., and Pirro M. C-reactive protein in hypertension: clinical significance and predictive value. Nutr Metab Cardiovasc Dis 16 (2006) 500-508
22. Schillaci G., Pirro M., Vaudo G., Gemelli F., Marchesi S., Porcellati C., and Mannarino E. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 43 (2004) 1817-1822
23. Verdecchia P., Porcellati C., Schillaci G., Borgioni C., Ciucci A., Battistelli M., Guerrieri M., Gatteschi C., Zampi I., Santucci A., Santucci C., and Reboldi G. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 24 (1994) 793-801 Erratum in: Hypertension 1995;25:462.
24. Schillaci G., Verdecchia P., Borgioni C., Ciucci A., Gattobigio R., Sacchi N., Benemio G., and Porcellati C. Predictors of diurnal blood pressure changes in 2042 subjects with essential hypertension. J Hypertens 14 (1996) 1167-1173
25. Schillaci G., Verdecchia P., Borgioni C., Ciucci A., Guerrieri M., Zampi I., Battistelli M., Bartoccini C., and Porcellati C. Improved electrocardiographic diagnosis of left ventricular hypertrophy. Am J Cardiol 74 (1994) 714-719
26. Verdecchia P., Schillaci G., Borgioni C., Ciucci A., Gattobigio R., Zampi I., and Porcellati C. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol 31 (1998) 383-390
27. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
28. Coller B.S. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?. Arterioscler Thromb Vasc Biol 25 (2005) 658-670
29. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
30. Wheeler J.G., Mussolino M.E., Gillum R.F., and Danesh J. Associations between differential leucocyte count and incident coronary heart disease. Eur Heart J 25 (2004) 1287-1292
31. Jacobi J., Sela S., Cohen H.I., Chezar J., and Kristal B. Priming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury. Am J Physiol Heart Circ Physiol 290 (2006) H2051-H2058
32. Sela S., Mazor R., Amsalam M., Yagil C., Yagil Y., and Kristal B. Primed polymorphonuclear leukocytes, oxidative stress, and inflammation antecede hypertension in the Sabra rat. Hypertension 44 (2004) 764-769
33. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
34. Dinerman J., and Mehta J. Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol 16 (1990) 207-222